Related Experiment Videos
Mammalian Raf-1 is activated by mutations that restore Raf signaling in Drosophila
1Molecular Basis of Carcinogenesis Laboratory, ABL-Basic Research Program, National Cancer Institute, Frederick Cancer Research and Development Center, MD 21702, USA.
Abstract:
An interaction with the Ras proto-oncogene product is a requirement for Raf-1 activation in many signaling cascades. The significance of this interaction is demonstrated by the fact that a mutation preventing the Ras-Raf interaction severely impairs the function of both mammalian (Raf-1) and Drosophila (D-Raf) Raf proteins. In D-Raf, however, dominant intragenic mutations have been identified that suppress the effect of the Ras-binding site (RBS) mutation. To address the mechanism by which these mutations restore Raf signaling, we have introduced the suppressor mutations into the analogous residues of mammalian Raf-1. Here, we show that rather than compensating for the RBS mutation by restoring the Ras-Raf-1 interaction, the suppressor mutations increase the enzymatic and biological activity of Raf-1, allowing Raf-1 to signal in the absence of Ras binding. Surprisingly, we find that while one of the suppressor mutations (P181L) increases the basal kinase activity of Raf-1, it also abolishes the ability of wild-type Raf-1 to become activated by Ras. This mutation occurs in the cysteine-rich domain (CRD) of Raf-1 and demonstrates the importance of this region for a productive Ras-Raf interaction. Finally, we present evidence that the most activating suppressor mutation (G498S) increases Raf-1 activity by introducing a novel phosphorylation site into the L12 activation loop of the Raf-1 kinase domain.
Insights
Suppressor mutations enhance Raf-1 kinase activity independently of Ras binding, revealing new signaling mechanisms. These mutations restore Raf signaling by increasing enzymatic function, not by restoring Ras interaction.
Area of Science:
- Molecular Biology
- Cell Signaling
- Oncogenesis
Background:
- Ras proto-oncogene product interaction is crucial for Raf-1 activation in signaling pathways.
- Mutations preventing Ras-Raf interaction impair Raf protein function.
- Dominant intragenic mutations in D-Raf suppress Ras-binding site mutations.
Purpose of the Study:
- Investigate the mechanism by which suppressor mutations restore Raf signaling.
- Introduce D-Raf suppressor mutations into mammalian Raf-1 to study their effects.
- Determine how these mutations impact Ras-Raf interaction and Raf-1 activity.
Main Methods:
- Site-directed mutagenesis to introduce suppressor mutations into mammalian Raf-1.
- Assays to measure Raf-1 enzymatic activity (kinase activity).
- Assessment of biological activity and Ras-binding capabilities of mutated Raf-1 proteins.
Main Results:
- Suppressor mutations increase Raf-1 enzymatic and biological activity, enabling signaling without Ras binding.
- One mutation (P181L) in the cysteine-rich domain increases basal kinase activity but prevents Ras-mediated activation.
- Another mutation (G498S) introduces a novel phosphorylation site, significantly increasing Raf-1 activity.
Conclusions:
- Suppressor mutations restore Raf signaling by enhancing intrinsic Raf-1 activity, not by restoring Ras interaction.
- The cysteine-rich domain is critical for productive Ras-Raf interaction.
- Novel phosphorylation sites can be introduced to modulate Raf-1 kinase activity and signaling.